States Deny Pricey Hepatitis C Drugs To Most Medicaid Patients
Effective treatments for hepatitis C cost as much as $95,000. Medicaid in many states, including Indiana, is mostly limiting the drugs' use to very advanced cases. ACLU of Indiana is suing the state.
Read more on NPR
No comments:
Post a Comment